Nuvectis Pharma, Inc. Earnings Per Share (Basic)
Nuvectis Pharma, Inc. (NVCT) reported Earnings Per Share (Basic) of -$0.30 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-04
- Nuvectis Pharma, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.30.
- Nuvectis Pharma, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.26.
- Nuvectis Pharma, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.32.
- Nuvectis Pharma, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.44.
- Nuvectis Pharma, Inc. earnings per share, basic for fiscal 2025 was -$1.32.
- Nuvectis Pharma, Inc. earnings per share, basic for fiscal 2024 was -$1.11.
- Nuvectis Pharma, Inc. earnings per share, basic for fiscal 2023 was -$1.43.
- Nuvectis Pharma, Inc. earnings per share, basic for fiscal 2022 was -$1.51.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.30 10-Q · filed 2026-08-04 | -$0.56 10-Q · filed 2026-08-04 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.30 derived: net income ÷ weighted average shares · filed 2026-08-04 | |
| 2026-03-31 | -$0.26 10-Q · filed 2026-05-05 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-05-05 | -$1.01 derived: net income ÷ weighted average shares · filed 2026-05-05 | -$1.30 derived: net income ÷ weighted average shares · filed 2026-08-04 | |
| 2025-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.32 10-K · filed 2026-02-11 | |
| 2025-09-30 | -$0.44 10-Q · filed 2025-11-04 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.01 10-Q · filed 2025-11-04 | -$1.36 derived: net income ÷ weighted average shares · filed 2026-08-04 | |
| 2025-06-30 | -$0.30 10-Q · filed 2026-08-04 | -$0.56 10-Q · filed 2026-08-04 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.16 derived: net income ÷ weighted average shares · filed 2026-08-04 | |
| 2025-03-31 | -$0.27 10-Q · filed 2026-05-05 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-05-05 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-05-05 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-05-05 | |
| 2024-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$1.11 10-K · filed 2026-02-11 | |
| 2024-09-30 | -$0.24 10-Q · filed 2025-11-04 | -$0.50 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$0.75 10-Q · filed 2025-11-04 | -$1.16 derived: net income ÷ weighted average shares · filed 2025-11-04 | |
| 2024-06-30 | -$0.26 10-Q · filed 2025-08-05 | -$0.51 10-Q · filed 2025-08-05 | -$0.92 derived: net income ÷ weighted average shares · filed 2025-08-05 | -$1.28 derived: net income ÷ weighted average shares · filed 2025-08-05 | |
| 2024-03-31 | -$0.25 10-Q · filed 2025-05-06 | -$0.66 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$1.02 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$1.40 derived: net income ÷ weighted average shares · filed 2025-05-06 | |
| 2023-12-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$0.77 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$1.15 derived: net income ÷ weighted average shares · filed 2025-02-25 | -$1.43 10-K · filed 2025-02-25 | |
| 2023-09-30 | -$0.37 10-Q · filed 2024-11-05 | -$0.74 derived: net income ÷ weighted average shares · filed 2024-11-05 | -$1.02 10-Q · filed 2024-11-05 | -$1.47 derived: net income ÷ weighted average shares · filed 2024-11-05 | |
| 2023-06-30 | -$0.38 10-Q · filed 2024-08-06 | -$0.65 10-Q · filed 2024-08-06 | -$1.11 derived: net income ÷ weighted average shares · filed 2024-08-06 | -$1.52 derived: net income ÷ weighted average shares · filed 2024-08-06 | |
| 2023-03-31 | -$0.27 10-Q · filed 2024-05-07 | -$0.73 derived: net income ÷ weighted average shares · filed 2024-05-07 | -$1.15 derived: net income ÷ weighted average shares · filed 2024-05-07 | -$1.44 derived: net income ÷ weighted average shares · filed 2024-05-07 | |
| 2022-12-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$0.88 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$1.17 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$1.51 10-K · filed 2024-03-05 | |
| 2022-09-30 | -$0.42 10-Q · filed 2023-11-08 | -$0.71 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$1.03 10-Q · filed 2023-11-08 | -$1.45 derived: net income ÷ weighted average shares · filed 2023-11-08 | |
| 2022-06-30 | -$0.28 10-Q · filed 2023-08-09 | -$0.59 10-Q · filed 2023-08-09 | -$1.00 derived: net income ÷ weighted average shares · filed 2023-08-09 | -$1.74 derived: net income ÷ weighted average shares · filed 2023-08-09 | |
| 2022-03-31 | -$0.32 10-Q · filed 2023-05-10 | $0.32 10-Q · filed 2022-05-12 | -$0.76 derived: net income ÷ weighted average shares · filed 2023-05-10 | -$1.63 derived: net income ÷ weighted average shares · filed 2023-05-10 | -$2.83 derived: net income ÷ weighted average shares · filed 2023-05-10 |
| 2021-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$1.54 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$2.93 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$3.02 10-K · filed 2023-03-08 | |
| 2021-09-30 | -$1.04 10-Q · filed 2022-11-08 | -$2.45 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$2.54 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | -$1.43 10-Q · filed 2022-08-10 | -$1.48 10-Q · filed 2022-08-10 | |||
| 2021-03-31 | $0.01 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |